Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Department of Neurology, University Medical Centre, Ljubljana, Slovenia.
J Alzheimers Dis. 2021;81(3):1253-1261. doi: 10.3233/JAD-201459.
Stroke and dementia are interrelated diseases and risk for both increases with age. Even though stroke incidence and age-standardized death rates have decreased due to prevention of stroke risk factors, increased utilization of reperfusion therapies, and other changes in healthcare, the absolute numbers are increasing due to population growth and aging.
To analyze predictors of death after stroke in patients with dementia and investigate possible time and treatment trends.
A national longitudinal cohort study 2007-2017 using Swedish national registries. We compared 12,629 ischemic stroke events in patients with dementia with matched 57,954 stroke events in non-dementia controls in different aspects of patient care and mortality. Relationship between dementia status and dementia type (Alzheimer's disease and mixed dementia, vascular dementia, other dementias) and death was analyzed using Cox regressions.
Differences in receiving intravenous thrombolysis between patients with and without dementia disappeared after the year 2015 (administered to 11.1% dementia versus 12.3% non-dementia patients, p = 0.117). One year after stroke, nearly 50% dementia and 30% non-dementia patients had died. After adjustment for demographics, mobility, nursing home placement, and comorbidity index, dementia was an independent predictor of death compared with non-dementia patients (HR 1.26 [1.23-1.29]).
Dementia before ischemic stroke is an independent predictor of death. Over time, early and delayed mortality in patients with dementia remained increased, regardless of dementia type. Patients with≤80 years with prior Alzheimer's disease or mixed dementia had higher mortality rates after stroke compared to patients with prior vascular dementia.
中风和痴呆是相互关联的疾病,两者的风险都随着年龄的增长而增加。尽管由于预防中风危险因素、再灌注治疗的应用增加以及医疗保健的其他变化,中风发病率和年龄标准化死亡率已经下降,但由于人口增长和老龄化,绝对数字仍在增加。
分析痴呆症患者中风后死亡的预测因素,并研究可能的时间和治疗趋势。
这是一项使用瑞典国家登记处的全国性纵向队列研究,时间为 2007 年至 2017 年。我们比较了痴呆症患者的 12629 例缺血性中风事件和非痴呆症对照组的 57954 例中风事件,在患者护理和死亡率的各个方面进行了比较。使用 Cox 回归分析痴呆症状态与痴呆症类型(阿尔茨海默病和混合性痴呆、血管性痴呆、其他痴呆症)和死亡之间的关系。
痴呆症患者和非痴呆症患者接受静脉溶栓治疗的差异在 2015 年后消失(给予 11.1%的痴呆症患者与 12.3%的非痴呆症患者,p=0.117)。中风后 1 年,近 50%的痴呆症患者和 30%的非痴呆症患者已经死亡。调整人口统计学、活动能力、疗养院安置和合并症指数后,痴呆症是与非痴呆症患者相比死亡的独立预测因素(HR 1.26 [1.23-1.29])。
中风前的痴呆症是死亡的独立预测因素。随着时间的推移,痴呆症患者的早期和晚期死亡率仍然增加,无论痴呆症类型如何。与有血管性痴呆症病史的患者相比,有阿尔茨海默病或混合性痴呆症病史的≤80 岁患者在中风后死亡率更高。